News

Who would you like to vote onto the EPHMRA Agency Board?
Who would you like to vote onto the EPHMRA Board?
Voting closes 14 May
It is voting time for the EPHMRA Agency Board members for 2025-2027. Once again we have a fantastic group of candidates - take a look at the web site for their full profiles.
It is a 2 year term of office starting 1 October 2025 and ending 30 September 2027 - one vote per company.

Basel meeting on 19 September 2024
‘Analysing the impact of Health Inequality: Unravelling the Business Question’
Meeting Convenors:
Ana Maria Aguirre-Arteta, Novartis

The 2024 Adverse Event Reporting Guidelines are now available.
The EPHMRA AER Guidelines have been written for Marketing Authorisation Holders (MAH/CH) or Certificate Holders and market research agencies (MRA) on the collection and reporting of an Adverse Event (AE) of medicinal products and medical devices.

Our final paper to be announced for the 2024 EPHMRA Basel Chapter meeting is entitled: Ethnic Disparities in Multiple Myeloma Treatment: A Holistic Analysis from Real-World Data.

As an Association we are happy to receive Code enquiries from EPHMRA Member companies.
These enquiries need to reference the section of the Code you have a question about, but we are unable to answer any questions of a commercial nature.
Our ethics consultants assess and review each question received and there is no charge for this service as it is a Member benefit.

The 2024 Basel Chapter meeting will be taking place 19 September at the Novartis Campus.
There we will be joined by Jeremy Hollow, Listen and Learn Research, to present their paper: Beyond Side Effects: Using social media to give a patient-centric understanding of medication adhere
Members can register for just 200

Our next paper at the 2024 Basel Chapter meeting, is called ‘Evaluating Consumer Preferences and Attitudes Through AI-Driven Patient Interviews’.
The speaker for this paper is – Mattia Marco Caruson, Mama Health Technologies

At the EPHMRA Basel Chapter meeting 2024, our paper from IQVIA will be entitled: The Inevitability of Bias (The Challenge Of Achieving Diversity).
This paper will be presented by speakers: Hafsah Rana and Sandra Flierl

19 September at the 2024 Basel Chapter meeting we will be joined by Lucy Oates, Narrative Health to present her paper: Closing the Gap in Health Equity; An Asthma Case Study.

Our first paper announced for the 2024 Basel Chapter meeting, is entitled...
‘The Patient Life Experience (PLE) Approach: Using social science methodology to examine diverse patient lives and reduce health’.